Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer
LAURION Broadens Advisor Network and Issues Stock Options to First Nations under Amended Exploration Agreement as Ishkoday Exploration Progresses
